Published in Biochem J on February 15, 1995
Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med (2008) 2.22
Absence of P-selectin delays fatty streak formation in mice. J Clin Invest (1997) 1.63
Minimally modified low-density lipoprotein induces monocyte adhesion to endothelial connecting segment-1 by activating beta1 integrin. J Clin Invest (1999) 1.14
Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases. Heart Vessels (2008) 0.98
Oxidized low-density lipoprotein contributes to atherogenesis via co-activation of macrophages and mast cells. PLoS One (2015) 0.79
Correlation between pretreatment serum LDL-cholesterol levels and prognosis in nasopharyngeal carcinoma patients. Onco Targets Ther (2016) 0.75
Coriandrum sativum L. seed extract mitigates lipotoxicity in RAW 264.7 cells and prevents atherogenic changes in rats. EXCLI J (2013) 0.75
Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl (1968) 60.35
Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest (1973) 31.28
The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (1993) 27.07
Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med (1989) 15.67
The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem (1977) 13.34
Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest (1991) 6.50
Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med (1993) 6.37
Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A (1984) 6.01
Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science (1991) 5.76
Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest (1989) 5.75
Vitamin E consumption and the risk of coronary disease in women. N Engl J Med (1993) 5.39
Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet (1992) 4.63
Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sci U S A (1981) 4.50
Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A (1990) 4.34
Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci U S A (1987) 4.10
PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell (1989) 3.95
Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest (1990) 3.40
Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J Biol Chem (1989) 3.34
Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature (1990) 3.11
Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J Cell Biol (1991) 3.05
A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol (1985) 3.02
Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun (1989) 2.81
Interleukin-1 activation of vascular endothelium. Effects on procoagulant activity and leukocyte adhesion. Am J Pathol (1985) 2.59
Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol (1991) 2.59
Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J Clin Invest (1985) 2.58
The human fibroblast class II extracellular matrix receptor mediates platelet adhesion to collagen and is identical to the platelet glycoprotein Ia-IIa complex. J Biol Chem (1988) 2.33
Cloning of the mouse endothelial selectins. Expression of both E- and P-selectin is inducible by tumor necrosis factor alpha. J Biol Chem (1992) 2.24
Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol (1992) 2.12
Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis (1987) 1.80
Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification. J Lipid Res (1988) 1.76
Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein. Proc Natl Acad Sci U S A (1985) 1.73
Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc Natl Acad Sci U S A (1990) 1.46
Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1. Am J Pathol (1994) 1.42
Leukocyte interactions mediated by selectins. Thromb Haemost (1991) 1.34
Structural and functional studies of the endothelial activation antigen endothelial leucocyte adhesion molecule-1 using a panel of monoclonal antibodies. J Immunol (1991) 1.27
Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N'-diphenyl-phenylenediamine. J Clin Invest (1992) 1.22
Improved measurement of low-density-lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein. Clin Chem (1992) 1.18
GMP-140: a receptor for neutrophils and monocytes on activated platelets and endothelium. J Cell Biochem (1991) 1.16
Lectin domain peptides from selectins interact with both cell surface ligands and Ca2+ ions. J Biol Chem (1992) 1.09
Inhibition of platelet functions by a monoclonal antibody (LYP20) directed against a granule membrane glycoprotein (GMP-140/PADGEM). Blood (1991) 0.97
Role of oxidized low density lipoprotein in atherogenesis. Prog Lipid Res (1992) 0.89
The vitronectin receptor (alpha v beta 3) is implicated, in cooperation with P-selectin and platelet-activating factor, in the adhesion of monocytes to activated endothelial cells. Biochem J (1994) 0.89
The role of platelet-activating factor in endothelial cells. Thromb Haemost (1990) 0.81
Planned and unplanned deliveries at home: implications of a changing ratio. Br Med J (Clin Res Ed) (1984) 2.37
Relation of haemoglobin levels in first and second trimesters to outcome of pregnancy. Lancet (1986) 2.24
Clinico-pathological findings in non-immune hydrops fetalis. Ir Med J (1991) 2.05
Objective birth data and the prediction of child abuse. Arch Dis Child (1981) 1.91
Altering the NICU and measuring infants' responses. Acta Paediatr (2000) 1.84
Control of flagellar wave movement in Crithidia oncopelti. Nature (1975) 1.60
Employment in pregnancy: prevalence, maternal characteristics, perinatal outcome. Lancet (1984) 1.54
The role of gatekeeping as a tool in healthcare delivery. Ir Med J (2002) 1.50
Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest (1982) 1.50
ICAM-1 deficiency reduces atherosclerotic lesions in double-knockout mice (ApoE(-/-)/ICAM-1(-/-)) fed a fat or a chow diet. Arterioscler Thromb Vasc Biol (2000) 1.47
Prevention of transmission of blood-borne diseases--a welcome beginning but a lost opportunity. Ir Med J (2000) 1.45
Expression of coagulation factor IX in a haematopoietic cell line. Thromb Haemost (2002) 1.44
Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1. Am J Pathol (1994) 1.42
The Holy Cross college football team hepatitis outbreak. JAMA (1972) 1.42
Effect on hepatic morphology of treatment of obesity by fasting, reducing diets and small-bowel bypass. N Engl J Med (1970) 1.41
Multicentre trial of ethamsylate for prevention of periventricular haemorrhage in very low birthweight infants. Lancet (1986) 1.40
Epidural versus general anaesthesia for elective caesarean section. Effect on Apgar score and acid-base status of the newborn. Anaesthesia (1989) 1.40
Umbilical cord prolapse--changing patterns and improved outcomes: a retrospective cohort study. BJOG (2014) 1.40
En bloc radical vulvectomy and lymphadenectomy with modifications of separate groin incisions. Obstet Gynecol (1992) 1.39
Pheochromocytoma, sickle cell disease and pregnancy: a case report. J Matern Fetal Neonatal Med (2003) 1.39
The QT interval enters mainstream medicine. Ir Med J (2004) 1.38
Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood (1992) 1.31
Effects of calcium on flagellar movement in the trypanosome Crithidia oncopelti. J Exp Biol (1976) 1.31
Plasma 17-hydroxyprogesterone concentrations in ill newborn infants. Arch Dis Child (1983) 1.30
Response to ACTH in the newborn. Arch Dis Child (1986) 1.29
Identification on human CD36 of a domain (155-183) implicated in binding oxidized low-density lipoproteins (Ox-LDL). Arterioscler Thromb Vasc Biol (1996) 1.25
The cell adhesion molecule CD31 is phosphorylated after cell activation. Down-regulation of CD31 in activated T lymphocytes. J Biol Chem (1992) 1.24
Radiographic screening at four months of infants at risk for congenital hip dislocation. J Bone Joint Surg Br (1992) 1.20
Absence of platelet membrane glycoproteins IIb/IIIa from monocytes. J Exp Med (1985) 1.20
Plants that express a potyvirus proteinase gene are resistant to virus infection. Proc Natl Acad Sci U S A (1993) 1.20
Identification of a domain (155-183) on CD36 implicated in the phagocytosis of apoptotic neutrophils. J Biol Chem (1996) 1.14
A monoclonal antibody (LYP18) directed against the blood platelet glycoprotein IIb/IIIa complex inhibits human melanoma growth in vivo. Blood (1989) 1.14
COX-2, VEGF and tumour angiogenesis. Surgeon (2009) 1.14
Glycoproteins of platelet membranes from Glanzmann's thrombasthenia. A comparison with normal using carbohydrate-specific or protein-specific labelling techniques and high-resolution two-dimensional gel electrophoresis. Eur J Biochem (1981) 1.13
The epidemiology of sudden infant death syndrome. J Epidemiol Community Health (1982) 1.11
The neurokinin A receptor activates calcium and cAMP responses through distinct conformational states. J Biol Chem (2001) 1.11
CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction. J Biol Chem (1992) 1.11
Blood spot glucocorticoid concentrations in ill preterm infants. Arch Dis Child (1987) 1.08
One-step procedure for the rapid isolation of mouse monoclonal antibodies and their antigen binding fragments by fast protein liquid chromatography on a mono Q anion-exchange column. J Chromatogr (1985) 1.03
A potyvirus polymerase interacts with the viral coat protein and VPg in yeast cells. Virology (1995) 1.03
Vascular biology of CD36: roles of this new adhesion molecule family in different disease states. Thromb Haemost (1997) 1.00
Thrombospondin induces dimerization of membrane-bound, but not soluble CD36. Thromb Haemost (1997) 0.99
Resistance of Capsicum annuum 'Avelar' to pepper mottle potyvirus and alleviation of this resistance by co-infection with cucumber mosaic cucumovirus are associated with virus movement. J Gen Virol (1999) 0.99
Monoclonal antibodies against platelet membrane glycoproteins. Characterization and effect on platelet function. Eur J Biochem (1983) 0.99
Acute appendicitis and social class. Br J Clin Pract (1982) 0.98
Maternal smoking and the timing of delivery. J Ir Med Assoc (1972) 0.98
Inhibition of platelet functions by a monoclonal antibody (LYP20) directed against a granule membrane glycoprotein (GMP-140/PADGEM). Blood (1991) 0.97
The effects of cigarette smoking, maternal age and parity on the outcome of pregnancy. J Ir Med Assoc (1974) 0.97
Birthweight-specific risk factors for necrotising enterocolitis. J Epidemiol Community Health (1987) 0.96
Complex formation of human thrombospondin with osteonectin. Eur J Biochem (1988) 0.96
Factors affecting the frequency infection in renal transplant recipients. Arch Intern Med (1976) 0.96
Presence of cytoadhesins (IIb-IIIa-like glycoproteins) on human metastatic melanomas but not on benign melanocytes. Am J Clin Pathol (1989) 0.95
Infectious lymphadenitis or lymphoma? Seven lessons. JAMA (1976) 0.94
Characterization of two murine monoclonal antibodies (P10, P12) directed against different determinants on human blood platelet thrombospondin. Eur J Biochem (1986) 0.94
Metabolic-inflammatory changes, and accelerated atherosclerosis in HIV patients: rationale for preventative measures. Curr Med Chem (2008) 0.93
Additional platelet membrane glycoprotein abnormalities in Glanzmann's thrombasthenia: A comparison with normals by high resolution two-dimensional polyacrylamide gel electrophoresis. Thromb Res (1980) 0.93
Impact of different low-dose ritonavir regimens on lipids, CD36, and adipophilin expression. Clin Pharmacol Ther (2008) 0.93
Retinopathy of prematurity screening, stress related responses, the role of nesting. Br J Ophthalmol (1997) 0.92
Human melanoma cell lines differ in their capacity to release ADP and aggregate platelets. Br J Haematol (1994) 0.92
Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets. Eur J Biochem (1988) 0.91
Role expansion or role extension: some conceptual differences. Nurs Forum (1970) 0.90
Identification of human platelet glycoproteins in SDS-polyacrylamide gels using 125I labelled lectins. Thromb Res (1979) 0.90
Genetic variation and covariation for resistance and tolerance to Cucumber mosaic virus in Mimulus guttatus (Phrymaceae): a test for costs and constraints. Heredity (Edinb) (2006) 0.90
The sonographic findings of splenic metastases. J Clin Ultrasound (1979) 0.90
Identification of an immunodominant functional domain on human CD36 antigen using human-mouse chimaeric proteins and homologue-replacement mutagenesis. Biochem J (1995) 0.90
Maternal erythropoietin in singleton pregnancies: a randomized trial on the effect of oral hematinic supplementation. Am J Obstet Gynecol (1994) 0.90
Basic aspects of bypassing agents. Haemophilia (2006) 0.89
The vitronectin receptor (alpha v beta 3) is implicated, in cooperation with P-selectin and platelet-activating factor, in the adhesion of monocytes to activated endothelial cells. Biochem J (1994) 0.89
Isolation of thrombospondin released from thrombin-stimulated human platelets by fast protein liquid chromatography on an anion-exchange Mono-Q column. J Chromatogr (1984) 0.89
Intramural gastric abscess. Am J Surg (1976) 0.88
The dialogue between endothelial cells and monocytes/macrophages in vascular syndromes. Curr Pharm Des (2007) 0.88
Two human melanoma cell-line variants with enhanced in vivo tumor growth and metastatic capacity do not express the beta 3 integrin subunit. Eur J Biochem (1994) 0.87
A comparison of the major platelet membrane glycoproteins from Bernard-Soulier syndrome with normals after radiolabelling of sialic acid or terminal galactose/N-acetylgalactosamine residues. Thromb Res (1980) 0.86
Studies on platelet glycoproteins in Glanzmann's thrombasthenia using 125I-labelled lectins. Br J Haematol (1980) 0.86
Stimulation of adhesion molecule expression by Helicobacter pylori and increased neutrophil adhesion to human umbilical vein endothelial cells. FEBS Lett (2002) 0.86
Micromanipulation of the flagellum of Crithidia oncopelti. I. Mechanical effects. J Exp Biol (1974) 0.86
Invasive markers identified by gene expression profiling in pancreatic cancer. Pancreatology (2011) 0.85
Cell attachment and fibrinogen binding properties of platelet and endothelial cell thrombospondin are not affected by structural differences in the 70 and 18 kDa protease-resistant domains. FEBS Lett (1988) 0.85
Comparison of the capacities of two prothrombin complex concentrates to restore thrombin generation in plasma from orally anticoagulated patients: an in vitro study. J Thromb Haemost (2008) 0.85
Description of 10 new mutations in platelet glycoprotein IIb (alphaIIb) and glycoprotein IIIa (beta3) genes. Platelets (2001) 0.84
Cloning of the cDNA encoding human platelet CD36: comparison to PCR amplified fragments of monocyte, endothelial and HEL cells. Thromb Haemost (1993) 0.84
Nickel increases susceptibility of a nickel hyperaccumulator to Turnip mosaic virus. J Environ Qual (2001) 0.83
Acute hyperglycaemia induces changes in the transcription levels of 4 major genes in human endothelial cells: macroarrays-based expression analysis. Thromb Haemost (2002) 0.83
New families of adhesion molecules play a vital role in platelet functions. Immunol Today (1990) 0.83
Senescent human neutrophil binding to thrombospondin (TSP): evidence for a TSP-independent pathway of phagocytosis by macrophages. Br J Haematol (1998) 0.83
Platelet membrane glycoprotein abnormalities in patients with myeloproliferative disorders and secondary thrombocytosis. Br J Haematol (1985) 0.83
Steroid therapy in uremic pericarditis. A report of three cases. JAMA (1974) 0.83
Identification of two distinct regions within the binding sites for fibrinogen and fibronectin on the IIb-IIIa human platelet membrane glycoprotein complex by monoclonal antibodies P2 and P4. Eur J Biochem (1986) 0.82
A monoclonal antibody directed against a granule membrane glycoprotein (GMP-140/PADGEM, P-selectin, CD62P) inhibits ristocetin-induced platelet aggregation. Br J Haematol (1996) 0.82
Helicobacter pylori induces cyclooxygenase-1 and cyclooxygenase-2 expression in vascular endothelial cells. Scand J Gastroenterol (2003) 0.82
Is screening for cervical cancer worthwhile? Ir J Med Sci (1980) 0.82
Characterization of two vaccinia CD36 recombinant-virus-generated monoclonal antibodies (10/5, 13/10): effects on malarial cytoadherence and platelet functions. Eur J Biochem (1997) 0.82
Cardiovascular and metabolic effects of cervical epinephrine infiltration. Obstet Gynecol (1985) 0.82
Vein of Galen aneurysm malformation (VGAM): closing the management loop. Ir Med J (2004) 0.82
Effect of naftazone on in vivo platelet function in the rat. Platelets (1999) 0.82